The European Medicines Agency (EMA) gives the green light to the use of the anticovid pill that halves the risk of death and hospitalisation. The EMA’s Committee for Medicinal Products for Human Use (CHMP) has endorsed the use of Merk and Ridgeback’s ‘Lagevrio’ (molnupiravir) to treat Covid-19. With this approval, Merk takes the lead in the […]
Coronavirus Present Situation in Africa – October
This document collects and analyses data on the evolution of COVID-19, collected by Johns Hopkins University and published daily by the European Documentation Centre of Almeria during the month of October 2021. COVID-19. Total data Africa Evolution of confirmed cases in Africa During the month of October, a total of 144,681 citizens were infected with […]
EMA clears Pfizer’s third dose for the general adult population
EMA recommendations on extra doses and boosters EMA’s human medicines committee (CHMP) has concluded that an extra dose of the COVID-19 vaccines Comirnaty (BioNTech/Pfizer) and Spikevax (Moderna) may be given to people with severely weakened immune systems, at least 28 days after their second dose. The recommendation comes after studies showed that an extra dose of these vaccines increased […]
Coronavirus evolution in Europe during August
The month of August ended with a total of 65,409,073 diagnosed cases of COVID-19, implying a monthly increase of 8.47%. Likewise, the number of COVID-19 deaths amounted to 1,277,013, 4.64% more than in the previous month. The following graph shows the evolution of confirmed cases and deaths from COVD-19 during the month mentioned above: The […]
Commission approves new contract for a potential COVID-19 vaccine with Novavax
The European Commission has approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022. Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 […]
€700 million for businesses affected by the COVID-19 crisis in Spain
The European Investment Bank (EIB) has signed a new agreement with Banco Sabadell under the Pan-European Guarantee Fund (EGF), which is part of the €540 billion package of measures with which the European Union is responding to the economic impact of COVID-19. The EIB will provide Banco Sabadell with a guarantee of up to €300 million to finance […]
EU research shows COVID-19 poised to end progress on gender equality
The social and economic impacts of the COVID-19 crisis threaten to roll back recent progress in gender equality, including an overall trend of upward convergence. Despite slow progress in some areas over the past decade, crucial improvements had been made in countries with lower levels of gender equality. The regressive consequences of COVID-19 on gender […]
COVID-19 evolution in Europe – 1st half 2021
Through data published by Johns Hopkins University and collected daily by the European Documentation Center in Almeria, an analysis of the evolution of the COVID-19 pandemic in Europe during the first half of the year 2021 has been performed. During the first half of 2021, COVID-19 cases continued to increase steadily. The European continent began […]
Vaccination in Europe – First semester 2021
Although the vaccination process is progressing steadily in all EU countries, the pace of vaccination is uneven in the different European territories, with some countries being more efficient in vaccinating their population. As of July 30, 39.21% of the EU/EEA population had received the full course of one of the EU-licensed vaccines and had therefore […]